Yapan Bio Private Limited
PrivateLast Round
Corporate Funding
Dec 21, 2021
Est. Valuation
$48.4M
Total Funding Raised
$13.45M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Yapan Bio Private Limited is a biotechnology company that provides contract development and manufacturing organization (CDMO) services for vaccines and biologics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Yapan Bio Private Limited Comparables
Compare Yapan Bio Private Limited with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kemwell | 78% | |
| Abzena | 76% | |
| WuXi Biologics | 76% | |
Yapan Bio Private Limited Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Dec 21, 2021 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 98% MoM.
- Nov 16, 2023
Grew 15% QoQ from 26 to 30 employees.
Yapan Bio Private Limited Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Yapan Bio Private Limited's valuation, stock price, and market status.